Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Minute Insight: Amazon Partners With Thread To Help Decentralize Clinical Trials

Executive Summary

Thread, a technology and consulting service provider, signed a deal with Amazon Web Services to enable faster, more efficient subject monitoring and data collection in clinical trials.

You may also be interested in...

Minute Insight: Thread Buys CureClick To Promote Participation In Clinical Trials

CureClick has developed the first “crowdsourcing” platform to accelerate awareness of and participation in clinical trials, which will help trial leaders reach traditionally underrepresented patient populations.

Bayer’s Koenen: Decentralized Trials For Pivotal Studies Not 'Black Or White Scenario'

A cross-section of biopharma experts including senior executives of Bayer, Boehringer Ingelheim and Accenture and US FDA Director at the India Office deliberate digitization and evolving trends in clinical research, including the potential of decentralized trials and metadata-driven automation.

Canada Seeks To Make Decentralized Trials More Practical For Sponsors

By formally adopting a modernized definition of a clinical trial site, Health Canada is hoping to provide greater flexibility to sponsors who want to incorporate decentralized elements in their trials.

Related Content


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts